158 related articles for article (PubMed ID: 32436411)
21. Long-wave plasma radiofrequency ablation for treatment of xanthelasma palpebrarum.
Baroni A
J Cosmet Dermatol; 2019 Feb; 18(1):121-123. PubMed ID: 29493071
[TBL] [Abstract][Full Text] [Related]
22. Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.
Hartmann F; Lockmann A; Grönemeyer LL; Haenssle HA; Zutt M; von Fintel H; Kühnle I; Schön MP; Thoms KM
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1372-1379. PubMed ID: 27911476
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of combination treatment for oculodermal melanocytosis: surgical reduction and use of 532-nm Q-switched Nd: YAG laser.
Park JH; Kim JY; Kim MJ; Tchah H
Cornea; 2014 Aug; 33(8):832-7. PubMed ID: 24915016
[TBL] [Abstract][Full Text] [Related]
24. The use of the 300 microsecond 1064 nm Nd:YAG laser in the treatment of keloids.
Rossi A; Lu R; Frey MK; Kubota T; Smith LA; Perez M
J Drugs Dermatol; 2013 Nov; 12(11):1256-62. PubMed ID: 24196333
[TBL] [Abstract][Full Text] [Related]
25. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
26. A Comparison Study of the Nonablative Fractional 1565-nm Er: glass and the Picosecond Fractional 1064/532-nm Nd: YAG Lasers in the Treatment of Striae Alba: A Split Body Double-Blinded Trial.
Zaleski-Larsen LA; Jones IT; Guiha I; Wu DC; Goldman MP
Dermatol Surg; 2018 Oct; 44(10):1311-1316. PubMed ID: 29746426
[TBL] [Abstract][Full Text] [Related]
27. 1064 nm Nd:YAG laser treatment of melanocytic nevi of the external auditory canal: a retrospective study of 15 cases.
Tong H; Zhang J; Li C; Fu Y; Zhang T
Lasers Med Sci; 2020 Dec; 35(9):2009-2014. PubMed ID: 32533471
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Xanthelasma Palpebrarum using Pulsed Dye Laser: Original Report on 14 Cases.
Thajudheen CP; Jyothy K; Arul P
J Cutan Aesthet Surg; 2019; 12(3):193-195. PubMed ID: 31619894
[TBL] [Abstract][Full Text] [Related]
29. Ultrapulse carbon dioxide laser ablation of xanthelasma palpebrarum: a case series.
Pathania V; Chatterjee M
J Cutan Aesthet Surg; 2015; 8(1):46-9. PubMed ID: 25949023
[TBL] [Abstract][Full Text] [Related]
30. Effective laser treatment options for argyria: Review of literatures.
Almurayshid A; Park S; Oh SH
J Cosmet Dermatol; 2020 Aug; 19(8):1877-1882. PubMed ID: 32538530
[TBL] [Abstract][Full Text] [Related]
31. Combined 585 nm pulsed-dye and 1,064 nm Nd:YAG lasers for the treatment of basal cell carcinoma.
Jalian HR; Avram MM; Stankiewicz KJ; Shofner JD; Tannous Z
Lasers Surg Med; 2014 Jan; 46(1):1-7. PubMed ID: 24272664
[TBL] [Abstract][Full Text] [Related]
32. Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema.
Panchaprateep R; Munavalli G
Lasers Surg Med; 2015 Feb; 47(2):148-55. PubMed ID: 25645645
[TBL] [Abstract][Full Text] [Related]
33. Treatment of periocular and temporal reticular veins with 1064-nm Nd:YAG Laser.
Lee TS; Kwek JWM; Ellis DAF
J Cosmet Dermatol; 2020 Sep; 19(9):2306-2312. PubMed ID: 32445602
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of purpuragenic 595 nm pulsed dye laser versus sequential emission of 595 nm pulsed dye laser and 1,064 nm Nd:YAG laser: a double-blind randomized controlled study.
Campos MA; Sousa AC; Varela P; Baptista A; Menezes N
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Mar; 28(1):1-5. PubMed ID: 30901061
[TBL] [Abstract][Full Text] [Related]
35. Pulsed dye laser versus long pulsed Nd:YAG laser in the treatment of angiokeratoma of Fordyce: A randomized, comparative, observer-blinded study.
Ibrahim SM
J Dermatolog Treat; 2016; 27(3):270-4. PubMed ID: 26371766
[TBL] [Abstract][Full Text] [Related]
36. Verruca vulgaris: novel treatment with a 1064 nm Nd:YAG laser.
Goldberg DJ; Beckford AN; Mourin A
J Cosmet Laser Ther; 2015 Apr; 17(2):116-9. PubMed ID: 25588038
[TBL] [Abstract][Full Text] [Related]
37. Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum.
Abdelkader M; Alashry SE
Saudi J Ophthalmol; 2015; 29(2):116-20. PubMed ID: 25892929
[TBL] [Abstract][Full Text] [Related]
38. [KTP laser coagulation for xanthelasma palpebrarum].
Berger C; Kopera D
J Dtsch Dermatol Ges; 2005 Oct; 3(10):775-9. PubMed ID: 16194155
[TBL] [Abstract][Full Text] [Related]
39. Q-switched Nd:YAG laser treatment for labial lentigines associated with Peutz-Jeghers syndrome.
Ge Y; Jia G; Lin T
J Dtsch Dermatol Ges; 2015 Jun; 13(6):551-5. PubMed ID: 26018367
[TBL] [Abstract][Full Text] [Related]
40. Treatment of xanthelasma palpebrarum with argon laser photocoagulation. Argon laser and xanthelasma palpebrarum.
Basar E; Oguz H; Ozdemir H; Ozkan S; Uslu H
Int Ophthalmol; 2004 Jan; 25(1):9-11. PubMed ID: 15085969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
